Literature DB >> 18258375

Antisocial personality disorder as a predictor of criminal behaviour in a longitudinal study of a cohort of abusers of several classes of drugs: relation to type of substance and type of crime.

Mats Fridell1, Morten Hesse, Mads Meier Jaeger, Eckart Kühlhorn.   

Abstract

Mixed findings have been made with regard to the long-term predictive validity of antisocial personality disorder (ASPD) on criminal behaviour in samples of substance abusers. A longitudinal record-linkage study of a cohort of 1052 drug abusers admitted 1977-1995 was undertaken. Subjects were recruited from a detoxification and short-term rehabilitation unit in Lund, Sweden, and followed through criminal justice registers from their first treatment episode to death or to the year 2004. In a ML multinomial random effects regression, subjects diagnosed with antisocial personality disorders were 2.16 times more likely to be charged with theft only (p<0.001), and 2.44 times more likely to be charged committing multiple types of crime during an observation year (p<0.001). The findings of the current study support the predictive validity of the DSM-III-R diagnosis of ASPD. ASPD should be taken seriously in drug abusers, and be targeted in treatment to prevent crime in society.

Entities:  

Mesh:

Year:  2008        PMID: 18258375     DOI: 10.1016/j.addbeh.2008.01.001

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  20 in total

1.  Association of COL25A1 with comorbid antisocial personality disorder and substance dependence.

Authors:  Dawei Li; Hongyu Zhao; Henry R Kranzler; David Oslin; Raymond F Anton; Lindsay A Farrer; Joel Gelernter
Journal:  Biol Psychiatry       Date:  2012-01-31       Impact factor: 13.382

2.  Initiating methadone in jail and in the community: Patient differences and implications of methadone treatment for reducing arrests.

Authors:  Robert P Schwartz; Sharon M Kelly; Shannon Gwin Mitchell; Jan Gryczynski; Kevin E O'Grady; Jerome H Jaffe
Journal:  J Subst Abuse Treat       Date:  2018-11-19

3.  A psychometric reevaluation of the TCU criminal thinking scales (CTS).

Authors:  Thomas B Sease; George Joe; Jennifer Pankow; Wayne E K Lehman; Kevin Knight
Journal:  J Offender Rehabil       Date:  2022-03-15

4.  Crime-Specific Recidivism in Criminal Justice Clients with Substance Use-A Cohort Study.

Authors:  Anna Karlsson; Anders Håkansson
Journal:  Int J Environ Res Public Health       Date:  2022-06-22       Impact factor: 4.614

5.  Effect of D-amphetamine on emotion-potentiated startle in healthy humans: implications for psychopathy and antisocial behaviour.

Authors:  Philip J Corr; Veena Kumari
Journal:  Psychopharmacology (Berl)       Date:  2012-08-03       Impact factor: 4.530

6.  Criminogenic Needs, Substance Use, and Offending among Rural Stimulant Users.

Authors:  Christine Timko; Brenda M Booth; Xiaotong Han; Nicole R Schultz; Daniel M Blonigen; Jessie J Wong; Michael A Cucciare
Journal:  Rural Ment Health       Date:  2017-04

7.  Risk factors for criminal recidivism - a prospective follow-up study in prisoners with substance abuse.

Authors:  Anders Håkansson; Mats Berglund
Journal:  BMC Psychiatry       Date:  2012-08-15       Impact factor: 3.630

8.  Substance abuse and psychiatric co-morbidity as predictors of premature mortality in Swedish drug abusers: a prospective longitudinal study 1970-2006.

Authors:  Anna Nyhlén; Mats Fridell; Martin Bäckström; Morten Hesse; Peter Krantz
Journal:  BMC Psychiatry       Date:  2011-07-30       Impact factor: 3.630

9.  Buprenorphine maintenance program with contracted work/education and low tolerance for non-prescribed drug use: a cohort study of outcome for women and men after seven years.

Authors:  Leif Öhlin; Mats Fridell; Anna Nyhlén
Journal:  BMC Psychiatry       Date:  2015-03-24       Impact factor: 3.630

10.  Psycho-education for substance use and antisocial personality disorder: a randomized trial.

Authors:  Birgitte Thylstrup; Sidsel Schrøder; Morten Hesse
Journal:  BMC Psychiatry       Date:  2015-11-14       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.